This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-09-1918v1 69/16/6367    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Markiewski, M. M. Articles by Lambris, J. D. PubMed PubMed Citation Articles by Markiewski, M. M. Articles by Lambris, J. D. Related Collections Tumor Biology Tumor Biology: Inflammation and Immune Escape

Unwelcome Complement

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Requests for reprints: J.D. Lambris, Protein Chemistry Laboratory, 401 Stellar Chance, Philadelphia, PA 19104. Phone: 215-746-5765; Fax: 215-573-8738; E-mail: lambris{at}upenn.edu.

For decades, the complement system has been recognized as an effector arm of the innate immunity system that contributes to the destruction of tumor cells. However, recent studies have challenged this paradigm by demonstrating that a complement component, the anaphylatoxin C5a, promotes the growth of malignant tumors in a mouse model of cervical carcinoma. The effect of C5a on tumor growth was associated with the recruitment of myeloid-derived suppressor cells to tumors, followed by the activation of these cells. These unexpected findings identify the complement system as a potential new target for anticancer immunotherapy. [Cancer Res 2009;69(16):6367–70]

This article has been cited by other articles:

				G. C. Prendergast Unifying Insights into Cancer Cell Signaling: Hedgehog, Cell Polarity, Complement, and CTLA-4 Polymorphisms Cancer Reviews Online Content, January 1, 2009; 2009(9): 17 - 18. [Full Text] [PDF]